← Back to Discover
B Group, Inc.
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $213,008,589
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- INVESCO QQQ TR · PUT · 46090E953 · shares · PUT: $36,820,000
- ADMA BIOLOGICS INC · COM · 000899104 · shares: $27,307,477
- PALISADE BIO INC · COM · 696389402 · shares: $23,855,856
- NRX PHARMACEUTICALS INC · COM NEW · 629444209 · shares: $16,735,327
- FAETH THERAPEUTICS INC · COM NEW · 81728A207 · shares: $15,254,225
- TAYSHA GENE THERAPIES INC · COM SHS · 877619106 · shares: $12,261,786
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $11,127,415
- CELLECTIS S A · SPON ADS · 15117K103 · shares: $9,844,503
- ZAI LAB LTD · ADR · 98887Q104 · shares: $8,562,274
- STRUCTURE THERAPEUTICS INC · SPONSORED ADS · 86366E106 · shares: $7,513,800
Reported holdings
19 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| INVESCO QQQ TR | PUT | 46090E953 | PUT | 50,000 shares | $36,820,000 |
| ADMA BIOLOGICS INC | COM | 000899104 | — | 3,262,542 shares | $27,307,477 |
| PALISADE BIO INC | COM | 696389402 | — | 11,414,285 shares | $23,855,856 |
| NRX PHARMACEUTICALS INC | COM NEW | 629444209 | — | 4,091,767 shares | $16,735,327 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 610,169 shares | $15,254,225 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 1,800,556 shares | $12,261,786 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 33,237 shares | $11,127,415 |
| CELLECTIS S A | SPON ADS | 15117K103 | — | 3,281,501 shares | $9,844,503 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 450,646 shares | $8,562,274 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 140,000 shares | $7,513,800 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 75,000 shares | $7,137,750 |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | — | 1,500,000 shares | $6,240,000 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 70,000 shares | $6,214,600 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 764,243 shares | $5,426,125 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 175,706 shares | $4,828,401 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 67,500 shares | $4,738,500 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | — | 135,000 shares | $4,507,650 |
| SIGHT SCIENCES INC | COM | 82657M105 | — | 970,000 shares | $3,656,900 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 200,000 shares | $976,000 |